TSO3 (TSE:TOS) had its target price trimmed by National Bank Financial from C$2.25 to C$1.75 in a research report report published on Thursday morning. The firm currently has a sector perform rating on the stock.
A number of other analysts also recently weighed in on the company. Canaccord Genuity downgraded TSO3 from a buy rating to a speculative buy rating and cut their target price for the company from C$4.25 to C$2.75 in a research report on Friday, January 26th. Royal Bank of Canada downgraded TSO3 from an outperform rating to a sector perform rating and cut their target price for the company from C$4.25 to C$2.00 in a research report on Friday, January 26th. Scotiabank cut their target price on TSO3 from C$4.50 to C$2.75 and set an outperform rating for the company in a research report on Tuesday, January 30th. Finally, Desjardins downgraded TSO3 from a buy rating to a hold rating in a research report on Friday, January 26th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock currently has an average rating of Hold and an average target price of C$2.12.
Shares of TSO3 stock opened at C$1.12 on Thursday. The firm has a market capitalization of $105.96, a price-to-earnings ratio of -10.18 and a beta of 1.11. TSO3 has a 1 year low of C$1.05 and a 1 year high of C$3.32.
TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.
Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.